Jean-Jacques Bosc
University of Bordeaux
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jean-Jacques Bosc.
European Journal of Medicinal Chemistry | 1992
Jean-Jacques Bosc; Christian Jarry; Alain Carpy; E Panconi; P Descas
Abstract The synthesis of 20 5-(1-aryl-4-piperazino)methyl-2-amino-2-oxazolines is described. Antidepressant activity was observed in mice using classical screening tests. Structure-activity relationships were studied and correlated with the nature of the aromatic substituent. Preliminary lipophilic and electronic properties of one lead compound (COR 3224) have been described.
Journal of Organometallic Chemistry | 1983
Mireille Bourhis; Jean-Jacques Bosc; René Golse
Abstract Reaction of organozinc compounds with a particular gem-aminoether ester, i.e. methyl-N,N-diethylamino methoxyacetate, leads to α-aminoesters. This method allows the synthesis of compounds having potential biological activity, viz. β-unsaturated α-aminoesters.
Journal of Pharmaceutical Sciences | 2000
C. Chaimbault; Jean-Jacques Bosc; J.M. Leger; Philippe Négrier; F. Capelle; Christian Jarry
The various crystalline forms of an original bicyclic compound [ethyl (2-chloromethyl-2,3-dihydro-5H-oxazolo[3, 2-a]pyrimidin-5-one)-6-carboxylate); EOC] have been obtained and characterized by powder and single-crystal X-ray diffraction, differential scanning calorimetry (DSC), and infrared (IR) and Raman spectroscopy. At 4 degrees C in methanol, a monoclinic racemate (form II) crystallized from the racemic mixture, whereas at 20 degrees C, an orthorhombic racemate (form I) was isolated in trichloroethylene. By increasing the temperature, a solid-solid transition from the stable form II to the stable form I was observed with a Guinier-Simon camera. A I --> II transformation was observed at ambient temperature by DSC.
Tetrahedron Letters | 1988
Mireille Bourhis; René Golse; Edwige Adjanohoun; Jean-Jacques Bosc; Michel Goursolle; Philippe Picard
Abstract Aminobicyclo (3.2.0) heptenones and aminonorbornenones were obtained from methylacrylate or acrylonitrile and captodative dienes. They result from respectively (2+2) and (4+2) cycloadditions.
Pharmacy and Pharmacology Communications | 2000
C. Chaimbault; Jean-Jacques Bosc; Christian Jarry; S. Daulouede; P. Vincendeau
One-step ring-annulation of 5-substituted 2-amino-2-oxazolines with diethyl ethoxymethy-lenemalonate yielded 2-substituted 6-carboethoxy-2,3-dihydro-5H-oxazolo[3,2-a]pyrimidin-5-ones. Under the same conditions 2-substituted 6-cyano-2,3-dihydro-5H-oxazolo[3,2-a]-pyrimidin-5-ones and the corresponding 2-ethyl(methylenecyanoacetate)-2-iminooxazo-lidines were obtained from ethyl ethoxymethylenecyanoacetate. Some of these compounds were evaluated in mice for antiparasitic activity.
European Journal of Medicinal Chemistry | 2010
Jean-Jacques Bosc; Laurent Latxague; Jean-Michel Leger; Jan Balzarini; Isabelle Forfar; Christian Jarry; Jean Guillon
Abstract A series of nucleoside derivatives was obtained via heteroatom annulation of the amino oxazoline of d-(−)-arabinose. Unequivocal proofs for the stereostructure of some new arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis. These newly synthesized compounds were then evaluated for their cytostatic activity against murine leukemia (L1210), and human T-lymphocytes (Molt 4/C8 and CEM). Of all the compounds in the series, the protected silylated tricyclic fused pyrimidinone 10 showed the most significant antitumor activity against murine leukemia L1210 (IC50 =6μM), and human T-lymphocytes cells Molt 4/C8 (IC50 =7.9μM) and CEM/0 cell lines (IC50 =7.5μM). None of the compounds exhibited significant antiviral inhibitory activities.
Pharmacy and Pharmacology Communications | 1999
C. Chaimbault; Jean-Jacques Bosc; Christian Jarry
Some N-phenyl(thio)carbamoyl-2-iminooxazolidines and 2-oxazolidinones were synthesized via 2-amino-2-oxazolines and tested as antiviral and antitumour agents. Moderate antitumour activity was found for the 5-(1-phenyl-4-piperazinyl)methyl substituted compounds.
Journal of Enzyme Inhibition and Medicinal Chemistry | 2002
Myriam Matoga; Isabelle Forfar; Corinne Chaimbault; Jean Guillon; Fabienne Pehourcq; Jean-Jacques Bosc; Marie-Claire Rettori; Christian Jarry
The derivatization of racemic 5-[(2-methylphenoxy)methyl]-2-amino-2-oxazoline, developed as an imidazoline binding sites ligand, with (+)- (R) - α -methylbenzyl isocyanate was performed in chloroform. The reaction led to two pairs of diastereomers, which were separated by RP-HPLC. A kinetic study of the derivatization reaction was achieved in order to establish conditions suitable for experimental drug monitoring.
Synthesis | 2007
Stéphane Massip; Jean Guillon; Pascal Sonnet; Jean-Michel Leger; Jean-Jacques Bosc; Christa E. Müller; Christian Jarry
8-(Dimethylamino)-3-(2-hydroxy-3-phenoxypropyl)--xanthine has been obtained from 6-amino-1-(2-hydroxy-3-phen-oxypropyl)uracil by an azodicarboxylate Michael-type addition involving a reactive diene. 6-Amino-1-(2-hydroxy-3-phenoxy--propyl)uracil was easily prepared from racemic 2-amino-5-(phen-oxymethyl)-2-oxazoline. Moreover, these chemical investigations also led to the identification of a racemic 7-aminooxazolo[5,4- D]pyrimidin-5(6 H)-one, obtained by the condensation reaction of the phosgeniminium chloride, Viehe’s salt, with 5,6-diamino-1-(2-hydroxy-3-phenoxypropyl)uracil.
Pharmacy and Pharmacology Communications | 1998
Isabelle Forfar; Jean-Jacques Bosc; J. M. Leger; Christian Jarry
An efficient synthesis of 2, 3, 6, 7-tetrahydro-3-phenyl-4H-oxazolo[3, 2-a]-1, 3, 5-triazin-2, 4-diones (4) is described. 2-Amino-2-oxazolines (1) were treated with electrophilic compounds to form, in two steps, 3-carboethoxy-2-phenylcarbamoyl-2-iminooxazolidines (3). These products were cyclized at high temperature in the presence of two equivalents of phenyl isocyanate. The structure of the 2, 3, 6, 7-tetrahydro-3-phenyl-7-methoxymethyl-4H-oxazolo[3, 2-a]-1, 3, 5-triazin-2, 4-dione (4a) was confirmed by X-ray crystallography.